T2HemoStat Detection Of Novel Clot Behavior Could Direct Therapeutic Choices For Stroke And Heart Attack Victims, T2 Biosystems Reveals

free biotech news

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

T2 Biosystems, a company developing direct detection products enabling superior diagnostics, announced that scientists from the University of Pennsylvania and T2 Biosystems have published a paper in Blood describing novel clot structure biology detected while testing T2 Bio’s T2HemoStat™. T2HemoStat is an innovative diagnostic tool for assessing blood clotting, platelet function, fibrinolytic activity and hematocrit measurements from a fingerstick blood sample in about 15 minutes.

Hey, check out all the engineering jobs. Post your resume today!

MORE ON THIS TOPIC